Nonetheless, the cumulative evidence ascribes MIP-2 a pro-tumorigenic role as a proangiogenic factor and a potent chemoattractant for neutrophils and MDSCs, involved in cancer-related immunosuppression. This evidence concerns the gene CXCL2 and cancer.